Who is sponsoring NCT05499026?

NCT05499026 is sponsored by Leadiant Biosciences Ltd..

What drugs are being tested in NCT05499026?

Interventions in NCT05499026: Chenodeoxycholic Acid.

What condition does NCT05499026 study?

NCT05499026 studies Cerebrotendinous Xanthomatoses.

Is NCT05499026 still recruiting?

NCT05499026 is currently completed. Last updated 12 August 2022.

Last reviewed 2022-08-12 · How we verify

NCT05499026

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

Completed Last updated 12 August 2022

What this trial tests

trial testing Chenodeoxycholic Acid in Cerebrotendinous Xanthomatoses in 28 participants. Completed in 3 June 2015.

Timeline

9 December 2014

Primary endpoint
3 June 2015

3 June 2015

Quick facts

Lead sponsor	Leadiant Biosciences Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	28
Start date	9 December 2014
Primary completion	3 June 2015
Estimated completion	3 June 2015

Drugs / interventions tested

Chenodeoxycholic Acid — full drug profile →

Conditions studied

Cerebrotendinous Xanthomatoses — all drugs for Cerebrotendinous Xanthomatoses →

Sponsor

Leadiant Biosciences Ltd.

Who can join

Eligibility, any sex, with Cerebrotendinous Xanthomatoses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective study of CTX patients to investigate the safety and clinical efficacy of Chenodeoxycholic Acid

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebrotendinous Xanthomatoses

Currently open trials in the same condition.

NCT03047369 — The Myelin Disorders Biorepository Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05499026 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leadiant Biosciences Ltd.
Last refreshed: 12 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499026.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing